Larvol Delta - Arcturus-Therapeutics-Receives-Clearance-of-an-Investigational-New-Drug-Application-to-US-Food-and-Drug-Administration-for-ARCT032-an-Investigational-Inhaled-mRNA-Therapeutic-to-Treat-Cystic-Fibrosis

ARCT-032 - Arcturus Therap

https://www.businesswire.com/news/home/20240903733506/en/Arcturus-Therapeutics-Receives-Clearance-of-an-Investigational-New-Drug-Application-to-U.S.-Food-and-Drug-Administration-for-ARCT-032-an-Investigational-Inhaled-mRNA-Therapeutic-to-Treat-Cystic-Fibrosis

Sep 3, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next